Loading
A phase 3 trial in lung cancer, run by Xin Ye, not yet recruiting.
Clinical Efficacy and Safety of Microwave Ablation Combined With Huaier Granules in Patients With Inoperable Stage IA Non-Small Cell Lung Cancer: A Prospective, Single-Center, Randomized Controlled Clinical Trial is a phase 3, randomised interventional study registered as NCT07197853 by Xin Ye, with a registry enrolment figure of 180 participants, started 2025-10-01 and due to reach its primary completion in 2028-06-30. Interventions recorded: Huaier Granule. Conditions listed: Non-small Cell Lung Cancer (NSCLC); Huaier Granules; Microwave Ablation. Primary outcome: Progression-Free Survival (PFS). Lung eligibility wording from the registry: "Histologically or cytologically confirmed IA stage non-small cell lung cancer (NSCLC) that is inoperable". No results are recorded here; the registry entry is the source.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.
Shares Lung cancer trials open today (registry snapshot), Non-small-cell lung cancer and the tag lung-deep-dive.